Related Experiment Videos
Risk predictors in patients with diabetic nephropathy
P Fioretto1, M L Caramori, M Dalla Vestra
1Department of Medical and Surgical Sciences, University of Padova Medical School, Via Giustiniani, n. 2, Padova 35128, Italy. paola.fioretto@unipd.it
Current Diabetes Reports
|March 20, 2003
Summary
Diabetic nephropathy is a leading cause of kidney failure. Early detection using microalbuminuria is crucial for identifying high-risk type 1 diabetes patients, guiding timely intervention to prevent end-stage renal disease.
Area of Science:
- Nephrology
- Endocrinology
- Diabetology
Background:
- Diabetic nephropathy is the primary cause of end-stage renal disease (ESRD) in Western nations.
- Identifying patients at high risk for nephropathy is critical due to the infeasibility of aggressive treatment for all.
Purpose of the Study:
- To review the predictive validity of microalbuminuria for overt nephropathy.
- To explore alternative and complementary markers for assessing nephropathy risk in diabetic patients.
Main Methods:
- Literature review focusing on studies evaluating microalbuminuria as a predictor.
- Analysis of existing research on various nephropathy risk markers.
Main Results:
- Microalbuminuria is currently the most established predictor of overt diabetic nephropathy.
- The review assesses the strengths and limitations of microalbuminuria and other potential markers.
Conclusions:
- Microalbuminuria remains a key early marker for diabetic nephropathy risk.
- Further research into a broader range of markers may enhance early risk identification and patient management.